Placental malaria is associated with attenuated CD4 T-cell responses to tuberculin PPD 12 months after BCG vaccination
- Equal contributors
1 MRC Laboratories Gambia, PO Box 273, Banjul, Gambia
2 Malawi-Liverpool-Wellcome Trust Clinical Research Programme, PO Box 30096, Chichiri, Blantyre 3, Malawi
3 Immunisation Department, Health Protection Agency Centre for Infections, London, UK
4 Department of Pediatrics, Bronx Lebanon Hospital Center, 1650 Selwyn Avenue, Bronx, New York, USA
5 Epidemiology and Surveillance Unit, Centre for Infectious Diseases Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands
6 Julius Centre, University Medical Centre Utrecht, Utrecht, The Netherlands
7 MRC Epidemiology Resource Centre, University of Southampton, Southampton General Hospital, Southampton, UK
BMC Infectious Diseases 2012, 12:6 doi:10.1186/1471-2334-12-6Published: 14 January 2012
Placental malaria (PM) is associated with prenatal malaise, but many PM+ infants are born without symptoms. As malaria has powerful immunomodulatory effects, we tested the hypothesis that PM predicts reduced T-cell responses to vaccine challenge.
We recruited healthy PM+ and PM- infants at birth. At six and 12 months, we stimulated PBMCs with tuberculin purified protein derivative (PPD) and compared expression of CD154, IL-2 and IFNγ by CD4 T-cells to a negative control using flow cytometry.
We measured the length, weight and head circumference at birth and 12 months.
IL-2 and CD154 expression were low in both groups at both timepoints, without discernable differences. Expression of IFNγ was similarly low at 6 months but by 12 months, the median response was higher in PM- than PM + infants (p = 0.026). The PM+ infants also had a lower weight (p = 0.032) and head circumference (p = 0.041) at 12 months, indicating lower growth rates.
At birth, the size and weight of the PM+ and PM- infants were equivalent. By 12 months, the PM+ infants had a lower weight and head circumference than the PM- infants.
Placental malaria was associated with reduced immune responses 12 months after immune challenge in infants apparently healthy at birth.